# OnCo record paper-balachandran-neoantigen-quality-long-term-survivors-nature-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-balachandran-neoantigen-quality-long-term-survivors-nature-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-balachandran-neoantigen-quality-long-term-survivors-nature-2017" ;
  schema:name "Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer"@en ;
  schema:description "The rare people who survive pancreatic cancer for years have tumours carrying both many mutation-made target proteins and plenty of killer T cells, and the quality of those targets, some resembling germ proteins, predicts long survival."@en ;
  schema:url <https://onco.cc/key-papers/paper-balachandran-neoantigen-quality-long-term-survivors-nature-2017/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/nature24462>, <https://pubmed.ncbi.nlm.nih.gov/29132146/> ;
  schema:sameAs <https://doi.org/10.1038/nature24462> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Balachandran VP, Luksza M, Zhao JN, et al." ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:technologies <https://onco.cc/technologies/neoantigen-mrna-vaccine/>, <https://onco.cc/technologies/wes-wgs/> ;
  onco:institutions <https://onco.cc/institutions/mskcc/> ;
  onco:pathways <https://onco.cc/pathways/antigen-presentation-immunoediting/>, <https://onco.cc/pathways/cancer-immunity-cycle/> ;
  onco:terms <https://onco.cc/terms/neoantigen/>, <https://onco.cc/terms/tmb/> ;
  onco:people <https://onco.cc/people/vinod-balachandran/> ;
  onco:journals <https://onco.cc/journals/nature/> .